clioquinol has been researched along with Leishmaniasis, Visceral in 1 studies
Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tavares, GSV | 1 |
| Mendonça, DVC | 1 |
| Miyazaki, CK | 1 |
| Lage, DP | 1 |
| Soyer, TG | 1 |
| Carvalho, LM | 1 |
| Ottoni, FM | 1 |
| Dias, DS | 1 |
| Ribeiro, PAF | 1 |
| Antinarelli, LMR | 1 |
| Ludolf, F | 1 |
| Duarte, MC | 1 |
| Coimbra, ES | 1 |
| Chávez-Fumagalli, MA | 1 |
| Roatt, BM | 1 |
| Menezes-Souza, D | 1 |
| Barichello, JM | 1 |
| Alves, RJ | 1 |
| Coelho, EAF | 1 |
1 other study available for clioquinol and Leishmaniasis, Visceral
| Article | Year |
|---|---|
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.
Topics: Amphotericin B; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Clioquino | 2019 |